When evaluating differences between the tumours, we identified Axl, a TAM (Tyro3/Axl/Mer) family receptor tyrosine kinase (RTK), to be highly expressed in the radioresistant tumour but not in the responsive tumour. Here, NTRK1 is linked to neoplasm.